Wedbush maintained its Outperform rating on Apple (NASDAQ:AAPL) noting that the company's next stage of product and AI driven ...

People have naturally kicked off over the affordability of the game if such a decision is taken by Rockstar or Take-Two. But ...

Tesla stock is gaining ground on the heels of two significant news items today. President Trump made a statement of support for the company and its CEO, Elon Musk, and Wedbush put out analysis ...

Experts have also weighed in on how much money GTA 6 might generate. While it took GTA 5 three days in make $1 billion, it's ...

It follows in the footsteps of Matthew Ball, a venture capitalise and analyst, who produced a 220 slide report on the gaming ...

and suspect that management can offer consumers an incentive to pay $100 or more per unit by rewarding them with a large ...

In a note to investors, Dan Ives, senior equity analyst for Wedbush Securities, called the company's China strategy the "biggest missing piece in Apple's AI launch," noting that it's been in a ...

As stocks continue sliding off a cliff, it can be difficult to discern which dips may be buying opportunities hiding in plain sight. According to Dan Ives, who leads technology research at Wedbush ...

According to the report, Siri in iOS 18 essentially has two separate systems. One is for classic Siri commands, such as ...

A co-founder of Reddit is looking to get involved with another popular online platform: TikTok.Entrepreneur Alexis Ohanian is ...

Wedbush analyst David Nierengarten maintained a Buy rating on Spyre Therapeutics (SYRE – Research Report) today and set a price target of $65.00. The company’s shares closed yesterday at $18. ...

“Tesla is clearly facing challenges in Europe and the Musk brand issues are adding to the headwinds,” Wedbush Securities analyst Dan Ives told AFP in a message, estimating that between 10 per ...